Grossman Williaminsider trades

In SEC Form 4 filings, Grossman William is listed as Interim Chief Medical Officer of enGene Therapeutics Inc. (ENGN). In the last 90 days, Grossman William bought $10.1K of enGene Therapeutics Inc. (ENGN) on the open market and sold none. The purchase was $10.1K of enGene Therapeutics Inc. (ENGN) on Sep 22.

Companies and roles

Company	Role	Transactions	Last filed
ENGNenGene Therapeutics Inc.	Interim Chief Medical Officer	1	Sep 24

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-24

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ENGNenGene Therapeutics Inc.	Sep 22	Sep 24	P	5,102	$1.97	Purchase +$10,051	5,102	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.